Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017 – Nasdaq
|
Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017
Nasdaq SYDNEY, Australia, Oct. 31, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) ("Prima") announces that Dr. Frédéric Triebel, Prima's Chief Scientific Officer and Medical Officer, gave an oral presentation at the World … |
